Product Information
GABAPENTIN 300 MG CAPSULE is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0324 per EA under NDC 50228018010. Its NADAC has been published 268 times since May 12, 2021.
The High Outlier badge above means this manufacturer's average price in the Gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228018010
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA204989On Market Since
2/18/2016
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 300 MG CAPSULE has been published 268 times since May 12, 2021, and over the history we have for it it has declined 32.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0324 per EA |
|---|---|
| All-time high | $0.0537 (Nov 10, 2021) |
| All-time low | $0.0313 (Nov 20, 2024) |
| 52-week high | $0.0361 |
| 52-week low | $0.0324 |
| Median price | $0.0410 |
| Average price | $0.0412 |
| Largest weekly change | -17.0% (Nov 20, 2024) |
| Weeks tracked | 268 |
| Tracking since | May 12, 2021 |
Generic Alternatives
The matcher finds 17 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 300 MG CAPSULE, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0324 per EA (NDC 50228018010), effective Jun 24, 2026.
How has the price of GABAPENTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 300 MG CAPSULE has declined 32.4%. It has been tracked across 268 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 300 MG CAPSULE?
Since May 12, 2021, the NADAC for GABAPENTIN 300 MG CAPSULE has ranged from a low of $0.0313 (Nov 20, 2024) to a high of $0.0537 (Nov 10, 2021), with a median of $0.0410 per EA.
Are there cheaper alternatives to GABAPENTIN 300 MG CAPSULE?
17 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 300 MG CAPSULE, but none are currently priced below it.
Who manufactures GABAPENTIN 300 MG CAPSULE?
GABAPENTIN 300 MG CAPSULE (NDC 50228018010) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification